Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/18/13 → 05/20/15 |
Funding
- Quintiles Incorporated: $5,875.00
Cardiorentis: Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure
- Skopicki, Hal A (PI)
- Singer, Adam (CoPI)
- Akande, Folashade (CoPI)
- Bloom, Michelle (CoPI)
- McCarthy-Santoro, Ellen (CoPI)
Project: Research